YIH
TEVA icon

Y-Intercept (HK)’s Teva Pharmaceuticals TEVA Stock Holding History

Y-Intercept (HK)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-302,995
Closed -$9.13M – 2159
2026
Q1 		$9.13M Buy
+302,995
New +$9.75M 0.17% 129
2025
Q4 		– Sell
-111,196
Closed -$2.25M – 1980
2025
Q3 		$2.25M Buy
111,196
+98,520
+777% +$1.73M 0.05% 550
2025
Q2 		$212K Sell
12,676
-180,711
-93% -$2.92M 0.01% 1448
2025
Q1 		$2.97M Buy
193,387
+63,241
+49% +$1.13M 0.2% 115
2024
Q4 		$2.87M Buy
+130,146
New +$2.37M 0.19% 136
2024
Q3 		– Sell
-34,493
Closed -$561K – 1791
2024
Q2 		$561K Buy
+34,493
New +$531K 0.03% 764
2023
Q3 		– Sell
-52,744
Closed -$397K – 1583
2023
Q2 		$397K Buy
+52,744
New +$428K 0.04% 661
2023
Q1 		– Sell
-101,632
Closed -$927K – 1531
2022
Q4 		$927K Buy
+101,632
New +$887K 0.14% 217
2022
Q2 		– Sell
-145,411
Closed -$1.36M – 1186
2022
Q1 		$1.36M Buy
+145,411
New +$1.21M 0.31% 67
2021
Q4 		– Sell
-112,151
Closed -$1.09M – 876
2021
Q3 		$1.09M Buy
+112,151
New +$1.05M 0.2% 166
2021
Q2 		– Sell
-13,649
Closed -$155K – 895
2021
Q1 		$155K Buy
+13,649
New +$157K 0.04% 568

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Y-Intercept (HK)'s TEVA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 302,995 shares — an estimated $9.13M sold.

Y-Intercept (HK) first reported a position in TEVA in Q1 2021 and held it in 11 quarters. The position peaked at $9.13M in Q1 2026. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 302,995 Teva Pharmaceuticals shares in Q2 2026, an estimated $9.13M.
  • Y-Intercept (HK) first reported a position in Teva Pharmaceuticals in Q1 2021 and held it in 11 quarters.
  • Y-Intercept (HK)'s Teva Pharmaceuticals position peaked at $9.13M in Q1 2026.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.